Medication info
Telmisartan Plus Tablet 80/12.5mg

Telmisartan Plus Tablet 80/12.5mg

Prescription medicationTablet경구
Ingredient · strength
Telmisartan›80mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
(주)팜젠사이언스
Appearance
White or almost white, biconvex, round tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 201903553 · Approved 2019.05.29 · Insurance code 670104380

Summary

Main use
Treatment for hypertension control in essential hypertension
Who takes it
Adults · Children
Adult dose
For patients whose blood pressure is not adequately controlled with telmisartan monotherapy, take this medication once daily with or without food. It is recommended to adjust the dosage of each component individually before administration. - The telmisartan/hydrochlorothiazide combination of 40/12.5mg can be administered to patients whose blood pressure is not adequately controlled with 40mg of telmisartan. - The telmisartan/hydrochlorothiazide combination of 80/12.5mg can be administered to patients whose blood pressure is not adequately controlled with 80mg of telmisartan. - The telmisartan/hydrochlorothiazide combination of 80/25mg can be administered to patients whose blood pressure is not adequately controlled with a combination of 80mg of telmisartan and 12.5mg of hydrochlorothiazide. Sodium or volume depletion should be resolved before starting this medication. Patients with renal impairment: No dosage adjustment is necessary for patients with mild to moderate renal impairment. This medication should not be administered to patients with severe renal impairment (creatinine clearance <30 mL/min). Regular monitoring of renal function is recommended. Patients with liver impairment: This medication should be administered with caution in patients with mild to moderate liver impairment. Do not exceed a daily dosage of 40/12.5mg. This medication should not be administered to patients with severe liver impairment (see precautions 2). Thiazide diuretics should be used cautiously in patients with liver dysfunction. Elderly patients: No dosage adjustment is necessary. Pediatric patients: The safety and efficacy of this medication have not been established in children under 18 years of age.
Child dose
The safety and efficacy of this medication have not been established in children under 18 years of age.

Ingredients

Manufacturer
(주)팜젠사이언스

Efficacy & effects

Treatment for hypertension control in essential hypertension

  • Essential hypertension
View approved original text

This medication is used as an adjunct therapy for patients with essential hypertension who have difficulty controlling blood pressure with monotherapy of telmisartan. It effectively lowers blood pressure, reduces the risk of cardiovascular diseases, and aids in overall blood pressure management.

How to take

Adult dose

For patients whose blood pressure is not adequately controlled with telmisartan monotherapy, take this medication once daily with or without food. It is recommended to adjust the dosage of each component individually before administration. - The telmisartan/hydrochlorothiazide combination of 40/12.5mg can be administered to patients whose blood pressure is not adequately controlled with 40mg of telmisartan. - The telmisartan/hydrochlorothiazide combination of 80/12.5mg can be administered to patients whose blood pressure is not adequately controlled with 80mg of telmisartan. - The telmisartan/hydrochlorothiazide combination of 80/25mg can be administered to patients whose blood pressure is not adequately controlled with a combination of 80mg of telmisartan and 12.5mg of hydrochlorothiazide. Sodium or volume depletion should be resolved before starting this medication. Patients with renal impairment: No dosage adjustment is necessary for patients with mild to moderate renal impairment. This medication should not be administered to patients with severe renal impairment (creatinine clearance <30 mL/min). Regular monitoring of renal function is recommended. Patients with liver impairment: This medication should be administered with caution in patients with mild to moderate liver impairment. Do not exceed a daily dosage of 40/12.5mg. This medication should not be administered to patients with severe liver impairment (see precautions 2). Thiazide diuretics should be used cautiously in patients with liver dysfunction. Elderly patients: No dosage adjustment is necessary. Pediatric patients: The safety and efficacy of this medication have not been established in children under 18 years of age.

Child dose

The safety and efficacy of this medication have not been established in children under 18 years of age.

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can pose serious risks to the fetus. Patients who are allergic to any component of this medication or have specific liver or kidney disorders should not take it. Elderly patients, patients with high potassium levels, those with weakened liver function, or patients with heart valve diseases require special caution when using this medication. The hydrochlorothiazide component may cause electrolyte imbalances in the body, so potassium, sodium, and other levels in the blood should be regularly monitored during use. This medication can interact with other blood pressure medications or multiple drugs, so all medications currently being taken should be reported to a physician or pharmacist. Caution is needed while driving or operating machinery as dizziness or drowsiness may occur. In case of overdose, symptoms such as hypotension, electrolyte abnormalities, and dehydration may occur, and appropriate medical attention should be sought immediately. The safety and efficacy of this medication have not been established in children, so it is advisable not to use it in this population. This medication should be kept out of reach of children and should not be transferred to other containers.

Side effects and when to seek care immediately

Serious side effects

Hives, severe swelling (edema), angioedema, vascular edema (including fatal outcomes), chest tightness, difficulty breathing, respiratory distress, respiratory pain, lung inflammation, pulmonary edema, acute respiratory distress syndrome (ARDS), cold sweat, pallor, severe rash with fever, blisters, skin peeling, oral/ocular mucosal pain, jaundice (yellowing of skin or eyes), liver dysfunction/liver disorder, profound general malaise, sudden and extreme manifestations.

Mild side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disturbances
Show 25 more
  • dizziness
  • visual disturbances
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • lung inflammation
  • pulmonary edema
  • diarrhea
  • dry mouth
  • bloating
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • liver dysfunction/liver disorder
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • low back pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is advisable to maintain storage temperatures between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White or almost white, biconvex, round tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.